The p53 protein is known as a """"""""guardian of the genome"""""""" because of its crucial role in coordinating cellular responses to genotoxic stress. It is well accepted that Mdm2, a RING-finger E3 ubiquitin ligase, induces p53 ubiquitination and plays a major part in the scope of p53 regulation. Originally, the ubiquitin-proteasome pathway was thought to have a one way direction from substrate ubiquitination to degradation by the 26S proteasome. However, the discovery and emergence of deubiquitination enzymes (DUBs) changed the global view of the enzymatic process and quickly showed the incredible dynamics of this pathway. Our early finding that the Herpesvirus-Associated Ubiquitin-Specific Protease (HAUSP) interacts and stabilizes p53 by deubiquitination, was one of the first indications thatDUBs exhibited a specific role in the p53 pathway. Surprisingly, the simple linear model was obscured however with the subsequent findings that HAUSP deubiquitinates Mdm2 and is essential for controlling the Mdm2 stability in vivo. In addition to ubiquitinating p53, Mdm2 elicits high levels of self-ubiquitination which makes Mdm2 itself very liable in cells. Our studies demonstrate that HAUSP expression can rescue Mdm2 from self-ubiquitination. Moreover, SiRNA-mediated inactivation of endogenous HAUSP leads to unmanageable self-ubiquitination and destabilization of Mdm2, which indirectly results in p53 activation. These findings were further supported by the study of somatic HAUSP-knock out human cells (HCT116-HAUSP-/-) in Bert Vogelstein's lab and more recently confirmed in mouse HAUSP (-/-) embryos by our lab. Thus, our studies suggest a dynamic role of HAUSP-mediated deubiquitination in regulating the p53 pathway; however, it also raises more interesting questions regarding the precise function of HAUSP in vivo. For example, 1) what is the physiological role of HAUSP in p53 activation and tumorigenesis and 2) how are the HAUSP/Mdm2 and HAUSP/p53 interactions dynamically regulated? To understand the dynamic nature of this pathway, we will first try to elucidate the regulation of the HAUSP/Mdm2 interaction as well as the HAUSP/p53 interaction in vivo by posttranslational modifications (Aim1). To completely understand the biochemical role of HAUSP in p53 regulation, we plan to identify novel associated factor/ or regulators of the HAUSP complexes (Aim2). Finally, in Aim 3, we will develop a conditional HAUSP-null mouse to access the physiological role of HAUSP in the p53/Mdm2 pathway. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA129627-01
Application #
7301764
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Blair, Donald G
Project Start
2007-07-01
Project End
2012-05-31
Budget Start
2007-07-01
Budget End
2008-05-31
Support Year
1
Fiscal Year
2007
Total Cost
$301,515
Indirect Cost
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Tavana, Omid; Gu, Wei (2013) The Hunger Games: p53 regulates metabolism upon serine starvation. Cell Metab 17:159-61
Kon, Ning; Zhong, Jiayun; Qiang, Li et al. (2012) Inactivation of arf-bp1 induces p53 activation and diabetic phenotypes in mice. J Biol Chem 287:5102-11
Dai, Chao; Gu, Wei (2012) WTX: an unexpected regulator for p53. Mol Cell 45:581-2
Brooks, Christopher L; Gu, Wei (2011) p53 regulation by ubiquitin. FEBS Lett 585:2803-9
Brooks, Christopher L; Gu, Wei (2011) The impact of acetylation and deacetylation on the p53 pathway. Protein Cell 2:456-62
Kon, N; Zhong, J; Kobayashi, Y et al. (2011) Roles of HAUSP-mediated p53 regulation in central nervous system development. Cell Death Differ 18:1366-75
Li, Muyang; Gu, Wei (2011) A critical role for noncoding 5S rRNA in regulating Mdmx stability. Mol Cell 43:1023-32
Lee, James T; Shan, Jing; Gu, Wei (2010) Targeting the degradation of cyclin D1 will help to eliminate oncogene addiction. Cell Cycle 9:857-8
Dai, Chao; Gu, Wei (2010) p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med 16:528-36
Kon, N; Kobayashi, Y; Li, M et al. (2010) Inactivation of HAUSP in vivo modulates p53 function. Oncogene 29:1270-9

Showing the most recent 10 out of 15 publications